{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T19:46:02Z","timestamp":1777751162463,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515011883"],"award-info":[{"award-number":["2019A1515011883"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21977127"],"award-info":[{"award-number":["21977127"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377155"],"award-info":[{"award-number":["22377155"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.bioorg.2024.107114","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T11:23:41Z","timestamp":1704885821000},"page":"107114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of novel selective phosphodiesterase\u20111 inhibitors for the treatment of acute myelogenous leukemia"],"prefix":"10.1016","volume":"144","author":[{"given":"Mei-Ling","family":"Le","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Rong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run-Duo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Jiong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijun","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107114_b0005","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1038\/nrdp.2016.10","article-title":"Acute myeloid leukaemia","volume":"2","author":"Khwaja","year":"2016","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.bioorg.2024.107114_b0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41568-020-00315-z","article-title":"Advances in germline predisposition to acute leukaemias and myeloid neoplasms","volume":"21","author":"Klco","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2024.107114_b0015","doi-asserted-by":"crossref","unstructured":"L. F. Newell, R. J. Cook, Advances in acute myeloid leukemia, BMJ.375 (2021) n2026.","DOI":"10.1136\/bmj.n2026"},{"key":"10.1016\/j.bioorg.2024.107114_b0020","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1172\/JCI133344","article-title":"Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2","volume":"130","author":"Dutta","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioorg.2024.107114_b0025","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/2159-8290.CD-20-1375","article-title":"Chemotherapy induces senescence-like resilient cells capable of initiating AML Recurrence","volume":"11","author":"Duy","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2024.107114_b0030","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.apsb.2020.06.012","article-title":"Novel agents targeting leukemia cells and immune microenvironment for prevention and treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation","volume":"10","author":"Shi","year":"2020","journal-title":"Acta Pharm. Sin B."},{"key":"10.1016\/j.bioorg.2024.107114_b0035","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2024.107114_b0040","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/cancers6010436","article-title":"The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment","volume":"6","author":"Fajardo","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2024.107114_b0045","first-page":"305","article-title":"Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation","volume":"10","author":"Ahlstr\u00f6m","year":"2005","journal-title":"Cell Mol. Biol. Lett."},{"key":"10.1016\/j.bioorg.2024.107114_b0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/13543776.2022.2027910","article-title":"PDE1 inhibitors: a review of the recent patent literature (2008-present)","volume":"32","author":"Le","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2024.107114_b0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41569-022-00756-z","article-title":"Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure","volume":"20","author":"Kamel","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bioorg.2024.107114_b0060","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/mnfr.201100307","article-title":"Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1","volume":"55","author":"Abusnina","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bioorg.2024.107114_b0065","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/mc.22276","article-title":"Cyclic nucleotide phosphodiesterase-1C (PDE1C) drives cell proliferation, migration and invasion in glioblastoma multiforme cells in vitro","volume":"55","author":"Rowther","year":"2016","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bioorg.2024.107114_b0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cellsig.2010.08.015","article-title":"Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis","volume":"23","author":"Abusnina","year":"2011","journal-title":"Cell Signal."},{"key":"10.1016\/j.bioorg.2024.107114_b0075","first-page":"1119","article-title":"Characterization of phosphodiesterase 1 in human malignant melanoma cell lines","volume":"29","author":"Shimizu","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioorg.2024.107114_b0080","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1073\/pnas.93.20.11236","article-title":"Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells","volume":"93","author":"Jiang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U S a."},{"key":"10.1016\/j.bioorg.2024.107114_b0085","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.1021\/acs.jmedchem.0c00711","article-title":"Discovery of novel selective and orally bioavailable phosphodiesterase-1 inhibitors for the efficient treatment of idiopathic pulmonary fibrosis","volume":"63","author":"Wu","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107114_b0090","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1021\/acs.jmedchem.8b00374","article-title":"Discovery of potent and selective periphery-restricted quinazoline inhibitors of the cyclic nucleotide phosphodiesterase PDE1","volume":"61","author":"Humphrey","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107114_b0095","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1021\/acs.jmedchem.5b01751","article-title":"Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases","volume":"59","author":"Li","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107114_b0100","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1021\/acs.jmedchem.2c00458","article-title":"Structural modifications of nimodipine lead to novel pde1 inhibitors with anti-pulmonary fibrosis effects","volume":"65","author":"Huang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107114_b0105","article-title":"Identification of novel quinolin-2(1H)-ones as phosphodiesterase 1 inhibitors for the treatment of inflammatory bowel disease","author":"Zhang","year":"2023","journal-title":"J Med Chem."},{"key":"10.1016\/j.bioorg.2024.107114_b0110","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.apsb.2022.09.023","article-title":"Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia: suppression of neuroinflammation by blocking NF-\u03baB transcription regulation and activating cAMP\/CREB axis","volume":"13","author":"Zhou","year":"2023","journal-title":"Acta Pharm. Sin B."},{"key":"10.1016\/j.bioorg.2024.107114_b0115","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.apsb.2017.12.007","article-title":"Structure-based design, synthesis, and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors","volume":"8","author":"Wu","year":"2018","journal-title":"Acta Pharm. Sin B."},{"key":"10.1016\/j.bioorg.2024.107114_b0120","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107114_b0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3121\/cmr.2021.1607","article-title":"Immunohistochemical evaluation of PARP and caspase-3 as prognostic markers in prostate carcinomas","volume":"19","author":"Acar","year":"2021","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.bioorg.2024.107114_b0130","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.apsb.2021.10.020","article-title":"Blockade of deubiquitinase YOD1 degrades oncogenic PML\/RAR\u03b1 and eradicates acute promyelocytic leukemia cells","volume":"12","author":"Shao","year":"2022","journal-title":"Acta Pharm. Sin B."},{"key":"10.1016\/j.bioorg.2024.107114_b0135","article-title":"Targeting apoptotic caspases in cancer","volume":"1867","author":"Boice","year":"2020","journal-title":"BBA-Mol. Cell Res."},{"key":"10.1016\/j.bioorg.2024.107114_b0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2024.107114_b0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2024.107114_b0150","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1016\/j.apsb.2022.03.020","article-title":"Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin b."},{"key":"10.1016\/j.bioorg.2024.107114_b0155","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/sj.cdd.4401975","article-title":"Proapoptotic multidomain Bcl-2\/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities","volume":"13","author":"Reed","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioorg.2024.107114_b0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.apsb.2016.08.005","article-title":"How to unleash mitochondrial apoptotic blockades to kill cancers?","volume":"7","author":"Deng","year":"2017","journal-title":"Acta Pharm. Sin B."},{"key":"10.1016\/j.bioorg.2024.107114_b0165","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1021\/acs.jmedchem.9b00224","article-title":"Validation of phosphodiesterase-10 as a novel target for pulmonary arterial hypertension via highly selective and subnanomolar inhibitors","volume":"62","author":"Huang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107114_b0170","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.apsb.2020.04.003","article-title":"Discovery of highly selective and orally available benzimidazole-based phosphodiesterase 10 inhibitors with improved solubility and pharmacokinetic properties for treatment of pulmonary arterial hypertension","volume":"10","author":"Yang","year":"2020","journal-title":"Acta Pharm. Sin B."},{"key":"10.1016\/j.bioorg.2024.107114_b0175","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1124\/mol.61.1.222","article-title":"Action of (E)-2'-deoxy-2'-(fluoromethylene)cytidine on DNA metabolism: incorporation, excision, and cellular response","volume":"61","author":"Zhou","year":"2002","journal-title":"Mol. Pharmacol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:56:40Z","timestamp":1777463800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":35,"alternative-id":["S0045206824000191"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107114","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel selective phosphodiesterase\u20111 inhibitors for the treatment of acute myelogenous leukemia","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107114"}}